-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
GreenLight Biosciences Holdings, PBC quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q1 2023.
- GreenLight Biosciences Holdings, PBC Operating Income (Loss) for the quarter ending March 31, 2023 was -$28.3M, a 23.1% increase year-over-year.
- GreenLight Biosciences Holdings, PBC Operating Income (Loss) for the twelve months ending March 31, 2023 was -$155M, a 25% decline year-over-year.
- GreenLight Biosciences Holdings, PBC annual Operating Income (Loss) for 2022 was -$164M, a 51% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)